• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各州合并审查管理机构与各州对医院合并提出质疑有关,但价格仍在持续上涨。

States' Merger Review Authority Is Associated With States Challenging Hospital Mergers, But Prices Continue To Increase.

机构信息

Brent D. Fulton (

Jaime S. King is a professor of law and the John and Marylyn Mayo Chair in Health Law, Faculty of Law, University of Auckland, in Auckland, New Zealand.

出版信息

Health Aff (Millwood). 2021 Dec;40(12):1836-1845. doi: 10.1377/hlthaff.2021.00781.

DOI:10.1377/hlthaff.2021.00781
PMID:34871079
Abstract

States can challenge proposed hospital mergers by using antitrust laws to prevent anticompetitive harms. This observational study examined additional state laws-principally charitable trust, nonprofit corporation, health and safety, and certificate-of-need laws-that can serve as complements and substitutes for antitrust laws by empowering states to be notified of, review, and challenge proposed hospital mergers through administrative processes. During the period 2010-19, 862 hospital mergers were proposed, but only forty-two (4.9 percent) were challenged by states, including thirty-five by states without federal involvement, of which twenty-five (71.4 percent) originated in the eight states with the most robust merger review authority. The twenty-five challenges resulted in two mergers being blocked; three being abandoned; and twenty being approved with conditions, including seven with competitive-impact conditions. Hospital market concentration and prices increased at similar rates in these eight states versus other states, potentially because most challenges allowed mergers to proceed with conditions that did not adequately address competitive concerns. Although these findings do not reveal an optimal state framework, elements of advanced state merger review authority may have the potential to improve poorly functioning hospital markets.

摘要

各州可以利用反垄断法来挑战拟议中的医院合并,以防止竞争受损。本观察性研究探讨了其他州的法律——主要是慈善信托、非营利公司、健康和安全以及需要证明的法律——通过授权各州通过行政程序通知、审查和挑战拟议中的医院合并,可以作为反垄断法的补充和替代,以增强各州的能力。在 2010 年至 2019 年期间,提出了 862 起医院合并,但只有 42 起(4.9%)受到各州的挑战,其中 35 起涉及没有联邦参与的州,其中 25 起(71.4%)源自合并审查权最强大的八个州。这 25 项挑战导致两项合并被阻止;三项被放弃;二十项被批准,但附有条件,其中七项附有竞争影响条件。在这八个州和其他州,医院市场的集中和价格以相似的速度增长,这可能是因为大多数挑战都允许合并有条件进行,而这些条件并没有充分解决竞争问题。尽管这些发现并没有揭示出一个最佳的州框架,但先进的州合并审查权的要素可能有潜力改善运作不佳的医院市场。

相似文献

1
States' Merger Review Authority Is Associated With States Challenging Hospital Mergers, But Prices Continue To Increase.各州合并审查管理机构与各州对医院合并提出质疑有关,但价格仍在持续上涨。
Health Aff (Millwood). 2021 Dec;40(12):1836-1845. doi: 10.1377/hlthaff.2021.00781.
2
Feds need to get back in the game. Challenging anticompetitive hospital mergers keeps prices down, quality up.联邦政府需要重新参与进来。挑战反竞争的医院合并能够压低价格、提升质量。
Mod Healthc. 2002 Apr 29;32(17):25.
3
Federal antitrust merger enforcement standards: a good fit for the hospital industry?联邦反垄断合并执法标准:是否适合医院行业?
J Health Polit Policy Law. 1995 Spring;20(1):137-69. doi: 10.1215/03616878-20-1-137.
4
The impact of geographic market definition on the stringency of hospital merger control in Germany and the Netherlands.地理市场定义对德国和荷兰医院合并控制严格程度的影响。
Health Econ Policy Law. 2012 Jul;7(3):363-81. doi: 10.1017/S1744133112000011. Epub 2012 Feb 21.
5
Physician Practice Consolidation Driven By Small Acquisitions, So Antitrust Agencies Have Few Tools To Intervene.小型收购推动医生执业整合,因此反垄断机构几乎没有干预手段。
Health Aff (Millwood). 2017 Sep 1;36(9):1556-1563. doi: 10.1377/hlthaff.2017.0054.
6
Antitrust and hospital mergers: does the nonprofit form affect competitive substance?反垄断与医院合并:非营利形式会影响竞争实质吗?
J Health Polit Policy Law. 2006 Jun;31(3):511-29. doi: 10.1215/03616878-2005-004.
7
Changing antitrust prospects for hospital mergers.医院合并中不断变化的反垄断前景。
Health Syst Lead. 1997 Jan;4(1):4-12.
8
The Protection of Patients Under the Clayton Act.《克莱顿法案》对患者的保护
Fordham Law Rev. 2018 Apr;86(5):2473-509.
9
New factors in the antitrust regulation of hospital mergers.医院合并反垄断监管中的新因素。
J Healthc Manag. 1999 Sep-Oct;44(5):367-80; discussion 380-1.
10
Minimizing antitrust exposure in a virtual merger.在虚拟合并中尽量减少反垄断风险。
Healthc Financ Manage. 1999 Sep;53(9):38-44.

引用本文的文献

1
State Health Care Cost Commissions: Their Priorities and How States' Political Leanings, Commercial Hospital Prices, and Medicaid Spending Predict Their Establishment.州医疗保健成本委员会:它们的优先事项以及州的政治倾向、商业医院价格和医疗补助支出如何预测其设立情况。
Milbank Q. 2025 Jun;103(2):554-580. doi: 10.1111/1468-0009.70019. Epub 2025 May 26.
2
A Policy and Regulatory Framework to Promote Care Delivery Redesign and Production Efficiency in Health Care Markets.促进医疗保健市场护理服务重新设计与生产效率的政策和监管框架。
Milbank Q. 2025 Jun;103(2):316-348. doi: 10.1111/1468-0009.70016. Epub 2025 May 6.
3
Health Equity and Hospital Markets: Differences in the Association of Market Concentration and Quality of Care by Patient Race/Ethnicity and Payer.
健康公平与医院市场:按患者种族/族裔和支付方划分的市场集中度与医疗质量关联的差异
Med Care. 2025 Mar 18;63(8):565-72. doi: 10.1097/MLR.0000000000002123.
4
Market landscape and insurer-provider integration: the case of ambulatory surgery centers.市场格局与保险公司-医疗机构整合:以门诊手术中心为例
Health Aff Sch. 2024 Jun 11;2(6):qxae081. doi: 10.1093/haschl/qxae081. eCollection 2024 Jun.
5
Protecting Patients And Society In An Era Of Private Equity Provider Ownership: Challenges And Opportunities For Policy.在私募股权所有的时代保护患者和社会:政策的挑战与机遇。
Health Aff (Millwood). 2024 May;43(5):666-673. doi: 10.1377/hlthaff.2023.00942.
6
Considerations for state-imposed conditions on healthcare provider transactions.关于国家对医疗服务提供者交易施加条件的考量。
Front Public Health. 2023 Aug 16;11:1220624. doi: 10.3389/fpubh.2023.1220624. eCollection 2023.
7
Research and policy to strengthen the employer-sponsored health insurance market.加强雇主赞助医疗保险市场的研究与政策。
Health Serv Res. 2022 Jun;57(3):439-442. doi: 10.1111/1475-6773.13982. Epub 2022 Apr 25.